- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01375530
Screening av frivillige for kliniske studier
VRC 500: Screening av frivillige for kliniske utprøvinger av undersøkelsesprodukter og lisensierte produkter evaluert for forskningsformål
Background:
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work.
Objectives:
- To screen healthy volunteers for clinical trials at the NIAID VRC.
Eligibility:
- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies.
Design:
- Screening for healthy volunteers to participate in clinical trials is an ongoing process.
- Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed.
- Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status.
- Volunteers will not receive any investigational product in this screening protocol.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
The purpose of this study is to recruit and screen potential study subjects, mostly healthy volunteers, to determine if they are eligible for clinical trials of investigational products. This screening study also aims to characterize and analyze demographic information as well as laboratory and other medical findings in terms of how they may affect the eligibility of subjects for specific early phase clinical trials. All work will be conducted by the VRC Clinic of the National Institutes of Health or other IRB-approved sites that are collaborating with NIAID/VRC. Educational and recruitment materials on the investigational products and protocols will be
reviewed with and provided to subjects during participation in the screening protocol.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: VRC Recruitment
- Telefonnummer: (866) 833-5433
- E-post: vrcrecruitment@mail.nih.gov
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30030
- Fullført
- Emory University
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201-1595
- Aktiv, ikke rekrutterende
- Univ of MD School of Medicine Center for Vaccine Development & Global Health
-
Bethesda, Maryland, Forente stater, 20892
- Rekruttering
- National Institutes of Health Clinical Center
-
Ta kontakt med:
- VRC Clinic
- Telefonnummer: 301-451-8715
- E-post: vaccines@nih.gov
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104-6056
- Fullført
- University of Pennsylvania-UPenn
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Healthy volunteers
Beskrivelse
- INCLUSION CRITERIA:
Age: 18 years of age or older
Able and willing to complete the informed consent process
Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
EXCLUSION CRITERIA:
A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
Known to be pregnant or breast-feeding
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: OTHER
- Tidsperspektiver: OTHER
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
1
Healthy adults 18 - 60 years old |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
To screen subjects for their eligibility to participate in clinical trials.
Tidsramme: Ongoing
|
Duration of subject participation is variable, and may last from a few weeks to several months for each subject. |
Ongoing
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Lasonji A Holman, C.R.N.P., National Institute of Allergy and Infectious Diseases (NIAID)
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Antatt)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 110164
- 11-I-0164
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .